PLACENTAL SITE TROPHOBLASTIC TUMOUR: A CASE REPORT

Placental site trophoblastic tumour (PSTT) is a rarest type of gestational trophoblastic disease (GTD) with an incidence of 1/50,000–100,000 of all pregnancies. In contrary to other variants of GTD, it arises from the intermediate trophoblast at placental site, secretes minimal beta-hCG and very less sensitivity for chemotherapeutic agents. Patient presents with amenorrhoea and abnormal bleeding. Imaging modalities like ultrasonography and MRI helps in making the diagnosis but is conrmed after histological evaluation and immunohistochemistry (IHC) studies. Patients mostly present with tumour limited to the uterine body. The mainstay of treatment is total hysterectomy. The prognosis of patients with tumour limited to the uterus is good